カテゴリー： QYResearch, 世界

世界の血液脳関門輸送薬市場 2019年

【英語タイトル】Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X04677）・商品コード：DATA909X04677
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、血液脳関門輸送薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他に、用途別には、アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳がん、その他にセグメント区分し、血液脳関門輸送薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・血液脳関門輸送薬の世界市場概要
・血液脳関門輸送薬の製造コスト構成分析
・血液脳関門輸送薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・血液脳関門輸送薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・血液脳関門輸送薬のセグメント分析（種類別）
（キャリア媒介輸送、受容体媒介輸送、吸収媒介輸送、能動排出輸送、その他）
・血液脳関門輸送薬のセグメント分析（用途別）
（アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳がん、その他）
・血液脳関門輸送薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Cyclenium、BioAdvance、EIP Pharma、Bioasis、Immune Pharmaceuticals、AZ Therapies、Palobiofarma、Bach Pharma、BrainsGate、CarThera、Dainippon Sumitomo Pharma、Fluorinov Pharma、Fondazione Telethon、Minoryx、NewGen Therapeutics、）
・血液脳関門輸送薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Blood-Brain Barrier Transport Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Blood-Brain Barrier Transport Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood-Brain Barrier Transport Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood-Brain Barrier Transport Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood-Brain Barrier Transport Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others

Segment by Application
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Blood-Brain Barrier Transport Drugs
1.1 Definition of Blood-Brain Barrier Transport Drugs
1.2 Blood-Brain Barrier Transport Drugs Segment by Type
1.2.1 Global Blood-Brain Barrier Transport Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Blood-Brain Barrier Transport Drugs Segment by Applications
1.3.1 Global Blood-Brain Barrier Transport Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Global Blood-Brain Barrier Transport Drugs Overall Market
1.4.1 Global Blood-Brain Barrier Transport Drugs Revenue (2014-2025)
1.4.2 Global Blood-Brain Barrier Transport Drugs Production (2014-2025)
1.4.3 North America Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)
1.4.4 Europe Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)
1.4.5 China Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)
1.4.6 Japan Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)
1.4.8 India Blood-Brain Barrier Transport Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs
2.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
2.4 Industry Chain Structure of Blood-Brain Barrier Transport Drugs

3 Development and Manufacturing Plants Analysis of Blood-Brain Barrier Transport Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Blood-Brain Barrier Transport Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Blood-Brain Barrier Transport Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Blood-Brain Barrier Transport Drugs Production and Capacity Analysis
4.2 Blood-Brain Barrier Transport Drugs Revenue Analysis
4.3 Blood-Brain Barrier Transport Drugs Price Analysis
4.4 Market Concentration Degree

5 Blood-Brain Barrier Transport Drugs Regional Market Analysis
5.1 Blood-Brain Barrier Transport Drugs Production by Regions
5.1.1 Global Blood-Brain Barrier Transport Drugs Production by Regions
5.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Regions
5.2 Blood-Brain Barrier Transport Drugs Consumption by Regions
5.3 North America Blood-Brain Barrier Transport Drugs Market Analysis
5.3.1 North America Blood-Brain Barrier Transport Drugs Production
5.3.2 North America Blood-Brain Barrier Transport Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Blood-Brain Barrier Transport Drugs Import and Export
5.4 Europe Blood-Brain Barrier Transport Drugs Market Analysis
5.4.1 Europe Blood-Brain Barrier Transport Drugs Production
5.4.2 Europe Blood-Brain Barrier Transport Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Blood-Brain Barrier Transport Drugs Import and Export
5.5 China Blood-Brain Barrier Transport Drugs Market Analysis
5.5.1 China Blood-Brain Barrier Transport Drugs Production
5.5.2 China Blood-Brain Barrier Transport Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Blood-Brain Barrier Transport Drugs Import and Export
5.6 Japan Blood-Brain Barrier Transport Drugs Market Analysis
5.6.1 Japan Blood-Brain Barrier Transport Drugs Production
5.6.2 Japan Blood-Brain Barrier Transport Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Blood-Brain Barrier Transport Drugs Import and Export
5.7 Southeast Asia Blood-Brain Barrier Transport Drugs Market Analysis
5.7.1 Southeast Asia Blood-Brain Barrier Transport Drugs Production
5.7.2 Southeast Asia Blood-Brain Barrier Transport Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Blood-Brain Barrier Transport Drugs Import and Export
5.8 India Blood-Brain Barrier Transport Drugs Market Analysis
5.8.1 India Blood-Brain Barrier Transport Drugs Production
5.8.2 India Blood-Brain Barrier Transport Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Blood-Brain Barrier Transport Drugs Import and Export

6 Blood-Brain Barrier Transport Drugs Segment Market Analysis (by Type)
6.1 Global Blood-Brain Barrier Transport Drugs Production by Type
6.2 Global Blood-Brain Barrier Transport Drugs Revenue by Type
6.3 Blood-Brain Barrier Transport Drugs Price by Type

7 Blood-Brain Barrier Transport Drugs Segment Market Analysis (by Application)
7.1 Global Blood-Brain Barrier Transport Drugs Consumption by Application
7.2 Global Blood-Brain Barrier Transport Drugs Consumption Market Share by Application (2014-2019)

8 Blood-Brain Barrier Transport Drugs Major Manufacturers Analysis
8.1 Cyclenium
8.1.1 Cyclenium Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.1.2 Cyclenium Product Introduction, Application and Specification
8.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 BioAdvance
8.2.1 BioAdvance Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.2.2 BioAdvance Product Introduction, Application and Specification
8.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 EIP Pharma
8.3.1 EIP Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.3.2 EIP Pharma Product Introduction, Application and Specification
8.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bioasis
8.4.1 Bioasis Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.4.2 Bioasis Product Introduction, Application and Specification
8.4.3 Bioasis Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Immune Pharmaceuticals
8.5.1 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.5.2 Immune Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AZ Therapies
8.6.1 AZ Therapies Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.6.2 AZ Therapies Product Introduction, Application and Specification
8.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Palobiofarma
8.7.1 Palobiofarma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.7.2 Palobiofarma Product Introduction, Application and Specification
8.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bach Pharma
8.8.1 Bach Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.8.2 Bach Pharma Product Introduction, Application and Specification
8.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 BrainsGate
8.9.1 BrainsGate Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.9.2 BrainsGate Product Introduction, Application and Specification
8.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 CarThera
8.10.1 CarThera Blood-Brain Barrier Transport Drugs Production Sites and Area Served
8.10.2 CarThera Product Introduction, Application and Specification
8.10.3 CarThera Blood-Brain Barrier Transport Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Dainippon Sumitomo Pharma
8.12 Fluorinov Pharma
8.13 Fondazione Telethon
8.14 Minoryx
8.15 NewGen Therapeutics

9 Development Trend of Analysis of Blood-Brain Barrier Transport Drugs Market
9.1 Global Blood-Brain Barrier Transport Drugs Market Trend Analysis
9.1.1 Global Blood-Brain Barrier Transport Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Blood-Brain Barrier Transport Drugs Regional Market Trend
9.2.1 North America Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.2.2 Europe Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.2.3 China Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.2.4 Japan Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.2.5 Southeast Asia Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.2.6 India Blood-Brain Barrier Transport Drugs Forecast 2019-2025
9.3 Blood-Brain Barrier Transport Drugs Market Trend (Product Type)
9.4 Blood-Brain Barrier Transport Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Blood-Brain Barrier Transport Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Blood-Brain Barrier Transport Drugs
Table Global Blood-Brain Barrier Transport Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Blood-Brain Barrier Transport Drugs Production Market Share by Types in 2018
Figure Carrier-mediated Transport Product Picture
Figure Receptor-mediated Transport Product Picture
Figure Absorptive-mediated Transport Product Picture
Figure Active Efflux Transport Product Picture
Figure Others Product Picture
Table Global Blood-Brain Barrier Transport Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Blood-Brain Barrier Transport Drugs Consumption Market Share by Applications in 2018
Figure Alzheimer's Disease
Figure Epilepsy
Figure Parkinson's Disease
Figure Multiple Sclerosis
Figure Hunter's Syndrome
Figure Brain Cancer
Figure Others
Figure Global Blood-Brain Barrier Transport Drugs Revenue (Million USD) (2014-2025)
Figure Global Blood-Brain Barrier Transport Drugs Production (K Pcs) (2014-2025)
Figure North America Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Figure Europe Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Figure China Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Figure Japan Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Figure India Blood-Brain Barrier Transport Drugs Market Size (Million USD) (2014-2025)
Table Blood-Brain Barrier Transport Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs in 2018
Figure Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
Figure Industry Chain Structure of Blood-Brain Barrier Transport Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Blood-Brain Barrier Transport Drugs Manufacturing Plants Distribution
Table Blood-Brain Barrier Transport Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Blood-Brain Barrier Transport Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Blood-Brain Barrier Transport Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Blood-Brain Barrier Transport Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Blood-Brain Barrier Transport Drugs Production Share by Manufacturers in 2018
Table Blood-Brain Barrier Transport Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Blood-Brain Barrier Transport Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Blood-Brain Barrier Transport Drugs Revenue Share by Manufacturers in 2018
Table Blood-Brain Barrier Transport Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Blood-Brain Barrier Transport Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Blood-Brain Barrier Transport Drugs Production Market Share by Regions 2014-2019
Figure Global Blood-Brain Barrier Transport Drugs Production Market Share by Regions in 2018
Table Global Blood-Brain Barrier Transport Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Regions 2014-2019
Figure Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Regions in 2018
Table Global Blood-Brain Barrier Transport Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Blood-Brain Barrier Transport Drugs Consumption Market Share by Regions 2014-2019
Figure North America Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure China Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure India Blood-Brain Barrier Transport Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Blood-Brain Barrier Transport Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Blood-Brain Barrier Transport Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Blood-Brain Barrier Transport Drugs Market Share by Application (2014-2019)
Table Cyclenium Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Cyclenium Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table Cyclenium Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cyclenium Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table Cyclenium Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure Cyclenium Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table Cyclenium Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table BioAdvance Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table BioAdvance Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table BioAdvance Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioAdvance Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table BioAdvance Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure BioAdvance Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table BioAdvance Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table EIP Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table EIP Pharma Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table EIP Pharma Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table EIP Pharma Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table EIP Pharma Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure EIP Pharma Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table EIP Pharma Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table Bioasis Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Bioasis Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table Bioasis Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioasis Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table Bioasis Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure Bioasis Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table Bioasis Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table AZ Therapies Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table AZ Therapies Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table AZ Therapies Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AZ Therapies Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table AZ Therapies Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure AZ Therapies Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table AZ Therapies Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table Palobiofarma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Palobiofarma Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table Palobiofarma Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Palobiofarma Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table Palobiofarma Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure Palobiofarma Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table Palobiofarma Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table Bach Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Bach Pharma Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table Bach Pharma Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bach Pharma Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table Bach Pharma Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure Bach Pharma Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table Bach Pharma Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table BrainsGate Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table BrainsGate Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table BrainsGate Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BrainsGate Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table BrainsGate Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure BrainsGate Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table BrainsGate Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table CarThera Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table CarThera Blood-Brain Barrier Transport Drugs Product Introduction, Application and Specification
Table CarThera Blood-Brain Barrier Transport Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CarThera Blood-Brain Barrier Transport Drugs Production Growth Rate (2014-2019)
Table CarThera Blood-Brain Barrier Transport Drugs Production Market Share (2014-2019)
Figure CarThera Blood-Brain Barrier Transport Drugs Revenue Market Share (2014-2019)
Table CarThera Blood-Brain Barrier Transport Drugs Main Business and Markets Served
Table Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Fluorinov Pharma Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Fondazione Telethon Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table Minoryx Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Table NewGen Therapeutics Blood-Brain Barrier Transport Drugs Production Sites and Area Served
Figure Global Blood-Brain Barrier Transport Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Blood-Brain Barrier Transport Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Blood-Brain Barrier Transport Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Blood-Brain Barrier Transport Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Blood-Brain Barrier Transport Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Blood-Brain Barrier Transport Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Blood-Brain Barrier Transport Drugs by Application (2019-2025)
Table Blood-Brain Barrier Transport Drugs Distributors List
Table Blood-Brain Barrier Transport Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Cyclenium、BioAdvance、EIP Pharma、Bioasis、Immune Pharmaceuticals、AZ Therapies、Palobiofarma、Bach Pharma、BrainsGate、CarThera、Dainippon Sumitomo Pharma、Fluorinov Pharma、Fondazione Telethon、Minoryx、NewGen Therapeutics、

★調査レポート[世界の血液脳関門輸送薬市場 2019年] (コード：DATA909X04677)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血液脳関門輸送薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の血液希釈剤市場 2019年
    DATA909X04678 / QYResearch / 2019年11月15日 / ※本調査レポートは、血液希釈剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗凝固剤、抗血小板薬に、用途別には、注射用血液シンナー、経口血液シンナーにセグメント区分し、血液希釈剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・血液希釈剤の世界市場概要 ・血液希釈剤の製造コスト構成分析 ・血液希釈剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・血液希釈剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・血液希釈剤のセグメント分析（種類別） （抗凝固剤、抗血小板薬）...The global Blood-thinning Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Blood-thinning Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood-thinning Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Blood-thinning Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Blood-thinning Drugs manufacturing...
  • 世界の高血圧薬市場 2019年
    DATA909X09003 / QYResearch / 2019年11月20日 / ※本調査レポートは、高血圧薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ACEI、CCB、ARBに、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、高血圧薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・高血圧薬の世界市場概要 ・高血圧薬の製造コスト構成分析 ・高血圧薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・高血圧薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・高血圧薬のセグメント分析（種類別） （ACEI、CCB、ARB）...The global High Blood Pressure Drugs (Hypertension) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Blood Pressure Drugs (Hypertension) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Blood Pressure Drugs (Hypertension) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of High Blood Pressure Drugs (Hypertension) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の脳感知ヘッドバンド市場 2019年
    DATA909X04788 / QYResearch / 2019年11月15日 / ※本調査レポートは、脳感知ヘッドバンドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、iOS専用、Android向け、ios＆Android向け、その他に、用途別には、病院と健康ケア施設、家庭、その他にセグメント区分し、脳感知ヘッドバンドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・脳感知ヘッドバンドの世界市場概要 ・脳感知ヘッドバンドの製造コスト構成分析 ・脳感知ヘッドバンドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・脳感知ヘッドバンドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・脳感知ヘッドバンドのセグメント分析（種類別） （iOS専用、Android向け、ios＆Android向け、その他）...The global Brain Sensing Headband market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Brain Sensing Headband volume and value at global level, regional level and company level. From a global perspective, this report represents overall Brain Sensing Headband market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Brain Sensing Headband in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のワイヤレス脳センサー市場 2019年
    DATA909X17869 / QYResearch / 2019年11月22日 / ※本調査レポートは、ワイヤレス脳センサーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、脳波記録(EEG)装置、睡眠監視装置、アクセサリーに、用途別には、てんかん、認知症、パーキンソン病、ハンチントン病、片頭痛、脳卒中、外傷性脳損傷、睡眠障害にセグメント区分し、ワイヤレス脳センサーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ワイヤレス脳センサーの世界市場概要 ・ワイヤレス脳センサーの製造コスト構成分析 ・ワイヤレス脳センサーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ワイヤレス脳センサーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ワイヤレス脳センサーのセグメント分析（種類別） （脳波記録(EEG)装置、睡眠監視装置、アクセサリー）...The global Wireless Brain Sensors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wireless Brain Sensors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wireless Brain Sensors market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wireless Brain Sensors in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の防湿層市場 2019年
    DATA909X11595 / QYResearch / 2019年11月20日 / ※本調査レポートは、防湿層の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、6ミル、10ミル、15ミル、その他に、用途別には、住宅、商業、公共建築にセグメント区分し、防湿層の世界市場を分析しました。 ・エグゼクティブ・サマリー ・防湿層の世界市場概要 ・防湿層の製造コスト構成分析 ・防湿層の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・防湿層の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・防湿層のセグメント分析（種類別） （6ミル、10ミル、15ミル、その他）...The global Moisture Barrier market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Moisture Barrier volume and value at global level, regional level and company level. From a global perspective, this report represents overall Moisture Barrier market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Moisture Barrier in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Moisture Barrier manufacturing...
  • 世界の防湿コーティング剤市場 2019年
    DATA909X11594 / QYResearch / 2019年11月20日 / ※本調査レポートは、防湿コーティング剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エラストマーコーティング、アルミ箔、裏打ちアルミ、ポリエチレンプラスチックシート、その他に、用途別には、住宅、商業、公共建築にセグメント区分し、防湿コーティング剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・防湿コーティング剤の世界市場概要 ・防湿コーティング剤の製造コスト構成分析 ・防湿コーティング剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・防湿コーティング剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・防湿コーティング剤のセグメント分析（種類別） （エラストマーコーティング、アルミ箔、裏打ちアルミ、ポリエチレンプラスチックシート、その他）...The global Moisture Barrier Coatings market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Moisture Barrier Coatings volume and value at global level, regional level and company level. From a global perspective, this report represents overall Moisture Barrier Coatings market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Moisture Barrier Coatings in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の異常ヘモグロビン症薬市場 2019年
    DATA909X08940 / QYResearch / 2019年11月20日 / ※本調査レポートは、異常ヘモグロビン症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、サラセミア療法、鎌状赤血球症（SCD）療法、その他療法に、用途別には、アルファサラセミア、ベータサラセミア、鎌状赤血球症、Hbバリアント病にセグメント区分し、異常ヘモグロビン症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・異常ヘモグロビン症薬の世界市場概要 ・異常ヘモグロビン症薬の製造コスト構成分析 ・異常ヘモグロビン症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・異常ヘモグロビン症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・異常ヘモグロビン症薬のセグメント分析（種類別） （サラセミア療法、鎌状赤血球症（SCD）療法、その他療法）...The global Hemoglobinopathies Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemoglobinopathies Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemoglobinopathies Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hemoglobinopathies Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hemoglobinopathies Drugs manufacturing...
  • 世界の脳生検針市場 2019年
    DATA909X04786 / QYResearch / 2019年11月15日 / ※本調査レポートは、脳生検針の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FNAB、CNB、ATEC、MRIガイド付き、外科生検に、用途別には、病院および診療所、外来手術センター、ケアおよび治療センター、その他にセグメント区分し、脳生検針の世界市場を分析しました。 ・エグゼクティブ・サマリー ・脳生検針の世界市場概要 ・脳生検針の製造コスト構成分析 ・脳生検針の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・脳生検針の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・脳生検針のセグメント分析（種類別） （FNAB、CNB、ATEC、MRIガイド付き、外科生検）...The global Brain Biopsy Needles market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Brain Biopsy Needles volume and value at global level, regional level and company level. From a global perspective, this report represents overall Brain Biopsy Needles market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Brain Biopsy Needles in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆